K Medical Value Up Acquires DRTECH's 15 Billion Won CBs Securing 11.08% Voting Rights for Management Influence
Filer K Medical Value Up acquired DRTECH's 9th series convertible bonds worth 15 billion won and filed a new substantial shareholding report.
The conversion price is 1,360 won, higher than the current stock price of 976 won, but if converted, it would add 11.03 million shares or about 12.5% potential dilution.
The purpose is to exercise management influence, with preemptive consent rights on capital reduction, major asset disposals, etc.
[AI Summary]K Medical Value Up, a credible institution under KDB, secured influence equivalent to a major shareholder by acquiring 15 billion won CBs of DRTECH. Although immediate dilution is unlikely due to the conversion price above market, potential 12.5% dilution upon future conversion and the activist nature of the investment warrant close monitoring for long-term governance changes.